Effects of a Myofascial Technique on Biomechanical Properties of the Lumbar Myofascia of Chronic Low Back Pain Adults

October 31, 2022 updated by: Mélanie Morin, Université de Sherbrooke

Effects of a Myofascial Technique on Biomechanical Properties of the Lumbar Paraspinal Muscle and Thoracolumbar Fascia in Chronic Low Back Pain Adults Assessed by Elastography, Ultrasonography and Myometry

Non-specific low back pain is a worldwide health issue that remains poorly understood. Some authors have shown that the thoracolumbar fascia of low back pain adults presents changes in biomechanical properties. As it is richly endowed with pain receptors, the thoracolumbar fascia could therefore be a key contributor to this chronic pain condition. Myofascial techniques (MFTs) are commonly used in manual therapy by practitioners of various backgrounds to address fascia biomechanical properties, but there is a paucity of objective evidence on their effects on tissue state. Musculoskeletal ultrasonography, sonoelastography and myometry are emerging imaging techniques that can quantify the biomechanical properties of fascia and underlying muscle. These innovative techniques could in turn contribute to a better understanding of MFTs effects on fascial properties.

The main objective of this study is to evaluate the immediate effect of a standardized MFT on the elastography features of the lumbar paraspinal muscle and fascia (i.e. myofascial unit). The secondary objectives are to evaluate the immediate effects of a MFT on: i) ultrasonography features of the myofascial unit; ii) myometry features of the myofascial unit; ii) pain intensity.

Study Overview

Study Type

Interventional

Enrollment (Actual)

49

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Sherbrooke, Quebec, Canada, J1H 5N4
        • Centre de recherche du Centre hospitalier Universitaire de Sherbrooke

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • adults over 18 years of age,
  • lumbar pain and/or referred pain above or below the gluteal fold , with intensity > 3/10, persisting for > 6 months and presenting during the day > 50% of the time.

Exclusion Criteria:

  • history of serious spinal or lower extremity injury or surgery in the last year
  • identifiable back pain or known pathology
  • known rheumatological condition
  • oral or injectable corticosteroids in the lumbar spine within the last 3 months
  • psychiatric disorder
  • pregnancy
  • manual treatment of the lumbo-sacral region 1 month prior to the experimentation and during the week of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: TRIPLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Myofascial release technique group
Myofascial technique on the thoracolumbar fascia and lumbar paraspinal muscles
SHAM_COMPARATOR: Simulated myofascial release technique group
Superficial hands contact on the lumbar area

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in elastography features of the myofascial unit
Time Frame: Baseline (before treatment), post-treatment (immediately after treatment)
Evaluated with a shear wave sonoelastography device.
Baseline (before treatment), post-treatment (immediately after treatment)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in ultrasonography features of the myofascial unit
Time Frame: Baseline (before treatment) post-treatment (immediately after treatment)
Evaluated with a B-mode ultrasound imaging device
Baseline (before treatment) post-treatment (immediately after treatment)
Changes in myometry features of the myofascial unit
Time Frame: Baseline (before treatment) post-treatment (immediately after treatment)
Evaluated with a myotonometer
Baseline (before treatment) post-treatment (immediately after treatment)
Changes in pain intensity
Time Frame: Baseline (before treatment) post-treatment (immediately after treatment), at day 2 and at day 7 after the intervention
Numeric rating Scale (0 to 10; minimum = 0; maximum = 10; higher score means worst outcome)
Baseline (before treatment) post-treatment (immediately after treatment), at day 2 and at day 7 after the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 19, 2021

Primary Completion (ACTUAL)

July 8, 2022

Study Completion (ACTUAL)

July 15, 2022

Study Registration Dates

First Submitted

March 19, 2021

First Submitted That Met QC Criteria

April 1, 2021

First Posted (ACTUAL)

April 5, 2021

Study Record Updates

Last Update Posted (ACTUAL)

November 2, 2022

Last Update Submitted That Met QC Criteria

October 31, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low Back Pain

Clinical Trials on Myofascial release technique

3
Subscribe